Fundraising Fox

GTX INC /De

Memphis, US · Delaware corporation

Biotech

Founders & leadership

MS
Marc S. HanoverCo-founder
MS
Mitchell S. SteinerCo-founder
HP
Henry P. DoggrellExecutive
DC
Diane C. Young, M.D.Executive
JT
James T. DaltonExecutive
GA
Garry A. Neil, M.D.Named on SEC filing
JK
J. Kenneth GlassNamed on SEC filing
JR
J. R. Hyde, IIINamed on SEC filing
JT
Jason T. ShackelfordNamed on SEC filing
KS
Kenneth S. Robinson, M.D., M.Div.Named on SEC filing
MG
Michael G. Carter, M.D., Ch.B., F.R.C.P.Named on SEC filing
RJ
Robert J. Wills, Ph.D.Named on SEC filing

Reported raises · per SEC filings

Form D private placements

$128M disclosed across 8 rounds · 2014–2020

▶$6.5MraisedDec 2020 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William R. LaRueDirector
  • Xin Nakanishi, Ph.D.Director
  • Charles TheuerDirector
  • Robert Wills, Ph.D.Director
  • Man ChoDirector
  • James B. Breitmeyer, M.D., Ph.D.Director, Executive Officer
  • Richard VincentExecutive Officer
  • Igor Bilinsky, Ph.D.Executive Officer
  • Frank Hsu, M.D.Executive Officer
  • Gunnar F. KaufmannExecutive Officer
  • David HaleDirector
  • Michael G. Carter, M.D., ChB, FRCPDirector
  • Daniel Kisner, M.D.Director
Offering amount
$6.5M
Amount sold
$6.5M
Placement agents
H.C. Wainwright & Co., LLC, Rodman & Renshaw, LLC
First sale
Dec 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.7MraisedNov 2020 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James B. Breitmeyer, M.D., Ph.D.Director, Executive Officer
  • Richard VincentExecutive Officer
  • Igor Bilinsky, Ph.D.Executive Officer
  • Frank Hsu, M.D.Executive Officer
  • Gunnar F. KaufmannExecutive Officer
  • David HaleDirector
  • Man ChoDirector
  • Daniel Kisner, M.D.Director
  • William R. LaRueDirector
  • Xin Nakanishi, Ph.D.Director
  • Charles TheuerDirector
  • Robert Wills, Ph.D.Director
  • Michael G. Carter, M.D., ChB, FRCPDirector
Offering amount
$1.7M
Amount sold
$1.7M
Placement agents
Rodman & Renshaw, LLC, H.C. Wainwright & Co., LLC
First sale
Nov 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$382.5KraisedSep 2020 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Igor Bilinsky, Ph.D.Executive Officer
  • Gunnar F. KaufmannExecutive Officer
  • Richard VincentExecutive Officer
  • David HaleDirector
  • Daniel Kisner, M.D.Director
  • Charles TheuerDirector
  • William R. LaRueDirector
  • Frank Hsu, M.D.Executive Officer
  • James B. Breitmeyer, M.D., Ph.D.Director, Executive Officer
  • Xin Nakanishi, Ph.D.Director
  • Man ChoDirector
  • Robert Wills, Ph.D.Director
  • Michael G. Carter, M.D., ChB, FRCPDirector
Offering amount
$382.5K
Amount sold
$382.5K
Placement agents
Rodman & Renshaw, LLC, H.C. Wainwright & Co., LLC
First sale
Sep 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.5MraisedAug 2020 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard VincentExecutive Officer
  • Michael G. Carter, M.D., ChB, FRCPDirector
  • Man ChoDirector
  • Robert Wills, Ph.D.Director
  • James B. Breitmeyer, M.D., Ph.D.Director, Executive Officer
  • Xin Nakanishi, Ph.D.Director
  • David F. HaleDirector
  • Igor Bilinsky, Ph.D.Executive Officer
  • Charles TheuerDirector
  • Frank Hsu, M.D.Executive Officer
  • Gunnar F. KaufmannExecutive Officer
  • William R. LaRueDirector
  • Daniel Kisner, M.D.Director
  • Hazel M. AkerExecutive Officer
Offering amount
$3.5M
Amount sold
$3.5M
Sales commissions
$381.3K
Placement agents
Rodman & Renshaw, LLC, H.C. Wainwright & Co., LLC
First sale
Jul 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.8MraisedJun 2020 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James B. Breitmeyer, M.D., Ph.D.Director, Executive Officer
  • Xin Nakanishi, Ph.D.Director
  • Charles TheuerDirector
  • Igor Bilinsky, Ph.D.Executive Officer
  • Richard VincentExecutive Officer
  • Michael G. Carter, M.D., ChB, FRCPDirector
  • Frank Hsu, M.D.Executive Officer
  • Robert Wills, Ph.D.Director
  • Daniel Kisner, M.D.Director
  • Man ChoDirector
  • William R. LaRueDirector
  • Gunnar F. KaufmannExecutive Officer
  • David F. HaleDirector
  • Haxel M. AkerExecutive Officer
Offering amount
$2.8M
Amount sold
$2.8M
Sales commissions
$459.8K
Placement agents
H.C. Wainwright & Co., LLC, Rodman & Renshaw, LLC
First sale
May 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$48.5MraisedOct 2017 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Garry A. Neil, M.D.Director
  • Henry P. DoggrellExecutive Officer
  • Diane C. Young, M.D.Executive Officer
  • J. Kenneth GlassDirector
  • J. R. Hyde, IIIDirector
  • Jason T. ShackelfordExecutive Officer
  • Kenneth S. Robinson, M.D., M.Div.Director
  • Michael G. Carter, M.D., Ch.B., F.R.C.P.Director
  • Marc S. HanoverExecutive Officer, Director
  • Robert J. Wills, Ph.D.Executive Officer, Director
Offering amount
$78.2M
Amount sold
$48.5M
Sales commissions
$2.5M
Placement agents
Robert W. Baird & Co., Stifel Nicolaus & Company
First sale
Sep 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$43.4MraisedNov 2014 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Barrington J.A. FurrDirector
  • J. Kenneth GlassDirector
  • Marc S. HanoverExecutive Officer, Director
  • Kenneth S. RobinsonDirector
  • Jason ShackelfordExecutive Officer
  • Michael G. CarterDirector
  • Henry P. DoggrellExecutive Officer
  • J. R. Hyde, IIIDirector
Offering amount
$43.4M
Amount sold
$43.4M
First sale
Nov 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$21.3MraisedMar 2014 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Henry P. DoggrellExecutive Officer
  • Kenneth S. RobinsonDirector
  • Michael G. CarterDirector
  • James T. DaltonExecutive Officer
  • J. R. Hyde, IIIDirector
  • Mitchell S. SteinerExecutive Officer, Director
  • Barrington J.A. FurrDirector
  • Marc HanoverExecutive Officer
  • J. Kenneth GlassDirector
Offering amount
$21.3M
Amount sold
$21.3M
First sale
Mar 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded GTX INC /De?
GTX INC /De was founded by Marc S. Hanover, Mitchell S. Steiner.
How much funding has GTX INC /De raised?
GTX INC /De has disclosed $128M raised across 8 rounds.
Where is GTX INC /De headquartered?
GTX INC /De is headquartered in Memphis, US.